Climb Bio logo

Climb Bio Share Price (NASDAQ: CLYM)

$2.24

-0.06

(-2.61%)

Last updated on

Check the interactive Climb Bio Stock chart to analyse performance

Climb Bio stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.24
    Today's High:$2.38

    Day's Volatility :5.88%

  • 52 Weeks Low:$1.05
    52 Weeks High:$5.86

    52 Weeks Volatility :82.08%

Climb Bio Stock Returns

PeriodClimb Bio IncIndex (Russel 2000)
3 Months
89.83%
0.0%
6 Months
65.93%
0.0%
1 Year
-67.2%
0.0%
3 Years
-27.51%
-4.1%

Climb Bio Inc Key Stats

Check Climb Bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.3
Open
$2.38
Today's High
$2.38
Today's Low
$2.24
Market Capitalization
$155.9M
Today's Volume
$288.9K
52 Week High
$5.86
52 Week Low
$1.05
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.02
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-22.92%

Stock Returns calculator for Climb Bio Stock including INR - Dollar returns

The Climb Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Climb Bio investment value today

Current value as on today

₹38,081

Returns

₹61,919

(-61.92%)

Returns from Climb Bio Stock

₹67,204 (-67.2%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Climb Bio Stock

332%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Climb Bio Stock from India on INDmoney has increased by 332% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Climb Bio Stock

Rating
Trend

Climb Bio Share Price Target

What analysts predicted

Upside of 301.79%

Target:

$9.00

Current:

$2.24

Climb Bio share price target is $9.00, a slight Upside of 301.79% compared to current price of $2.24 as per analysts' prediction.

Climb Bio Stock Insights

  • Price Movement

    In the last 1 month, CLYM stock has moved up by 60.0%
  • CLYM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 137.9%
  • CLYM vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 142.8%

Climb Bio Technicals Summary

Sell

Neutral

Buy

Climb Bio is currently in a neutral trading position according to technical analysis indicators.

Climb Bio Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Climb Bio Inc logo
54.48%
65.93%
-67.2%
-27.51%
-85.91%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Climb Bio Inc

Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN). The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.
Organization
Climb Bio
Employees
17
CEO
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Industry
Miscellaneous

Key Management of Climb Bio Inc

NameTitle
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Interim Principal Financial Officer, CEO, President & Director
Ms. Chandra Adams J.D.
VP & General Counsel
Dr. Nishi Rampal M.D.
Senior Vice President of Clinical Development
Ms. Janaki M. Subramanyam M.Sc.
VP & Head of Regulatory Affairs
Ms. Kate Hecht M.B.A.
Senior Vice President of Program Management
Dr. Perrin Wilson B.S., Ph.D.
Chief Business Officer
Dr. Edgar D. Charles M.D., M.Sc.
Chief Medical Officer
Ms. Cindy J. Driscoll M.B.A.
Senior Vice President of Finance

Important FAQs about investing in CLYM Stock from India :

What is Climb Bio share price today?

Climb Bio share price today is $2.24 as on at the close of the market. Climb Bio share today touched a day high of $2.38 and a low of $2.24.

What is the 52 week high and 52 week low for Climb Bio share?

Climb Bio share touched a 52 week high of $5.86 and a 52 week low of $1.05. Climb Bio stock price today i.e. is closed at $2.24, lower by 61.77% versus the 52 week high.

How to invest in Climb Bio Stock (CLYM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Climb Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Climb Bio Shares that will get you 0.6696 shares as per Climb Bio share price of $2.24 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Climb Bio Stock (CLYM) from India?

Indian investors can start investing in Climb Bio (CLYM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Climb Bio stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Climb Bio share’s latest price of $2.24 as on August 30, 2025 at 1:29 am IST, you will get 4.4643 shares of Climb Bio. Learn more about fractional shares .

What are the returns that Climb Bio has given to Indian investors in the last 5 years?

Climb Bio stock has given -85.91% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?